Dimitris Voliotis

Insider Reports History

Entity
Individual
Location
C/O Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York, NY
Signature
/s/ Melissa B. Epperly, Attorney-in-Fact for Dimitris Voliotis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dimitris Voliotis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. SVP, Clinical Development Stock Option (Right to Buy) 24.2K $1.16M $47.80 Feb 10, 2022 Direct
Zentalis Pharmaceuticals, Inc. SVP, Clinical Development Common Stock 16K $164K $10.29 Feb 14, 2022 Direct

Insider Reports Filed by Dimitris Voliotis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZNTL Zentalis Pharmaceuticals, Inc. Feb 10, 2022 4 -$30.2K 4 Feb 14, 2022 SVP, Clinical Development
ZNTL Zentalis Pharmaceuticals, Inc. Jan 18, 2022 15 -$1.3M 4 Jan 20, 2022 SVP, Clinical Development